Radius Health (RDUS) Tops Q3 EPS by 36c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Radius Health, Inc.: Third Quarter 2020 Operating Results
November 5, 2020 8:00 AM ESTTYMLOS® U.S. net sales of $50 million with 8% year-over-year growth; Total Revenues of $78 millionQ3 commercial pivot to focus on high risk fracture segment is gaining traction: Net New U.S. Patients increased by 7+% in September 2020 vs. previous 3-month moving average and 10 +% in October vs. previous 3 month moving averageJapan market progress on track with our partner Teijin for expected 2021 abaloparatide injection launchThree Pivotal Trial Readouts on track for 2H 2021Conference call scheduled for 8:30 a.m. ET... More
